Research Article

Connexin 43 Is a Potential Prognostic Biomarker for Ewing Sarcoma/Primitive Neuroectodermal Tumor

Table 1

The pertinent pathological, clinical, and Cx43 immunohistochemical data.

CaseSexAgeLocationTumor size (cm)Cx43 scoreCx43 interpretationMetastasisTreatmentOSVS

1M24Chest wall10.5160.38PositiveNoS, C, R610Dead
2M17Lower lobe lung21.5112.45PositiveNoC, R623Dead
3F72Thigh6117.59PositiveNoS, C, R298Dead
4M28Pelvis148.62NegativeYesC, R222Dead
5M30Thigh1795.83PositiveNoS, C, R2743Alive
6F28Femur1263.19PositiveYesS,C, R522Alive
7M40Pelvis1018.49PositiveNoS, C, R1700Alive
8M17PelvisN/A55.05PositiveYesC, R1029Dead
9M24Pelvis12.760.17PositiveNoS, C, R1067Alive
10M59Thigh4.5110.12PositiveYesS, C1624Alive
11F15Shoulder/Humerus5.355.09PositiveNoS, C4036Alive
12M33Spine (T7)1.6140.11PositiveYesS, C, R209Dead
13F15Femur3.7126.51PositiveYesS, C701Dead
14F57Leg34.5144.65PositiveNoS, C505Dead
15M12Distal femur1172.41PositiveNoS, C, R5065Alive
16M35Flank383.9PositiveNoS, C, R3892Alive
17M58Thigh856.45PositiveYesS, C, R661Alive
18F35Fibula75.3NegativeNoS, C, R1301Alive
19M54Chest8135.54PositiveNoS, C, R681Dead
20M15Ilium7.578.71PositiveNoS, C, R1929Dead
21 M28Rib588.57PositiveNoS, C, R1553Dead
22F61Chest7.573.89PositiveNoS, C364Dead
23M16Pelvis7.512.71NegativeNoS, C, R1929Alive
24F16Rib550.25PositiveNoS, C2233Alive
25M14LegN/A16.61PositiveNoS, C637Alive
26F71Uterus1113.07NegativeYesS25Dead
27M29Thigh3014.43NegativeNoS, C, R2743Alive
28F41Lung817.25PositiveYesS, C, R2388Dead
29M34Chest wall5.732.34PositiveNoS, C1624Alive
30F67Lung7109.74PositiveYesS, C, R341Dead
31F20Brain1.21.24NegativeNoS, C, R806Alive
32F16Rib and diaphragm5104.5PositiveYesS, C, R711Dead
33M58Abdominal wall5.52.42NegativeNoS, C, R1204Live
34M37Brain22.94NegativeNoS, R664Live
35M24Cerebellum175.33PositiveNoS, R2109Live
36F47Brain255.68PositiveYesS, C, R211Dead

*S: Surgery; C: Chemotherapy; R: Radiation, OS: Overall survival rate; VS: Vital status.